Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Results of a Phase I Dose-Escalation Study Using Single-Fraction Stereotactic Radiotherapy for Lung Tumors

Results of a Phase I Dose-Escalation Study Using Single-Fraction Stereotactic Radiotherapy for... Single-fraction stereotactic RT is feasible for selected patients with lung tumors. For those with prior thoracic RT, 25 Gy may be too toxic. Higher dose was associated with improved local control. Longer follow-up is necessary to determine the treatment efficacy and toxicity. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Results of a Phase I Dose-Escalation Study Using Single-Fraction Stereotactic Radiotherapy for Lung Tumors

Donington, Jessica
Journal of Thoracic Oncology , Volume 1 (8) – Oct 1, 2006
Download PDF
8 pages

Loading next page...
 
/lp/wolters-kluwer-health/results-of-a-phase-i-dose-escalation-study-using-single-fraction-xG19T594Lc

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

Single-fraction stereotactic RT is feasible for selected patients with lung tumors. For those with prior thoracic RT, 25 Gy may be too toxic. Higher dose was associated with improved local control. Longer follow-up is necessary to determine the treatment efficacy and toxicity.

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Oct 1, 2006

There are no references for this article.